Dimensional Fund Advisors LP Rezolute, Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Rezolute, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 220,932 shares of RZLT stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220,932
Previous 254,479
13.18%
Holding current value
$1.83 Million
Previous $737,000
33.65%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RZLT
# of Institutions
95Shares Held
59.4MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$116 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$33.3 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$29.4 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$25.1 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$25.1 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $321M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...